
Kristen Kluska
Stock Analyst at Cantor Fitzgerald
(4.76)
# 650
Out of 5,134 analysts
403
Total ratings
43.1%
Success rate
17.2%
Average return
Main Sectors:
Stocks Rated by Kristen Kluska
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MNPR Monopar Therapeutics | Upgraded: Buy | $119 | $72.00 | +65.28% | 11 | Nov 12, 2026 | |
| LXEO Lexeo Therapeutics | Reiterated: Buy | $23 | $2.87 | +701.39% | 7 | Nov 11, 2026 | |
| CAPR Capricor Therapeutics | Reiterated: Buy | $28 | $9.53 | +193.81% | 17 | Nov 10, 2026 | |
| TSX: EPRX Eupraxia Pharmaceuticals Inc. | Reiterated: Buy | $27.12 | $11.65 | +132.75% | 13 | Nov 10, 2026 | |
| RIGL Rigel Pharmaceuticals | Reiterated: Hold | $47 | $44.46 | +5.71% | 16 | Nov 8, 2026 | |
| KARD Kardigan | Reiterated: Buy | $50 | $13.82 | +261.79% | 2 | Nov 7, 2026 | |
| ADMA ADMA Biologics | Reiterated: Hold | $12 → $13 | $13.68 | -4.97% | 14 | Nov 5, 2026 | |
| CLDX Celldex Therapeutics | Reiterated: Buy | $72 | $28.83 | +149.74% | 29 | Nov 5, 2026 | |
| STO: EGTX Egetis Therapeutics AB (publ) | Downgraded: Hold | kr 33.00 → kr 11.25 | kr 11.20 | +0.45% | 3 | Nov 5, 2026 | |
| SRPT Sarepta Therapeutics | Reiterated: Hold | $21 | $16.07 | +30.68% | 29 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $39 | $16.08 | +142.54% | 20 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $87 | $29.72 | +192.73% | 1 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $9.08 | +175.33% | 11 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $137 | $63.49 | +115.78% | 27 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $11.02 | +335.77% | 10 | Oct 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $441 | $273.09 | +61.49% | 1 | Oct 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $0.9999 | +500.06% | 1 | Oct 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $6.06 | - | 8 | Oct 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $125 → $170 | $80.00 | +112.50% | 19 | Oct 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $7.51 | +232.89% | 3 | Oct 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $30 | $2.42 | +1,139.67% | 12 | Sep 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $0.3075 | +875.61% | 11 | Sep 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $6.84 | +280.12% | 4 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $1.16 | +848.28% | 11 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $4.10 | +363.41% | 20 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $6.35 | +151.97% | 10 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $3.91 | +181.33% | 5 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $23.81 | - | 12 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $24 | $3.77 | +536.60% | 8 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 | $1.09 | +1,367.89% | 9 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $3.12 | +348.72% | 8 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $7 | $0.5584 | n/a | 4 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $3.98 | n/a | 6 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.9146 | n/a | 3 | Feb 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 → $20 | $0.413 | n/a | 2 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $13.38 | n/a | 3 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $1.64 | n/a | 3 | Jun 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $21.60 | n/a | 1 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.53 | n/a | 2 | Jun 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.5 → $28 | $0.1141 | n/a | 2 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $28 → $20 | $0.0001 | n/a | 3 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 6 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.25 → $10 | $0.7317 | n/a | 3 | Dec 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $180 | $1.68 | n/a | 1 | Dec 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 | $0.8278 | n/a | 6 | Sep 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.4214 | n/a | 4 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $0.0002 | n/a | 1 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $0.371 | n/a | 1 | Nov 30, 2020 |
Monopar Therapeutics
Nov 12, 2026
Upgraded: Buy
Price Target: $119
Current: $72.00
Upside: +65.28%
Lexeo Therapeutics
Nov 11, 2026
Reiterated: Buy
Price Target: $23
Current: $2.87
Upside: +701.39%
Capricor Therapeutics
Nov 10, 2026
Reiterated: Buy
Price Target: $28
Current: $9.53
Upside: +193.81%
Eupraxia Pharmaceuticals Inc.
Nov 10, 2026
Reiterated: Buy
Price Target: $27.12
Current: $11.65
Upside: +132.75%
Rigel Pharmaceuticals
Nov 8, 2026
Reiterated: Hold
Price Target: $47
Current: $44.46
Upside: +5.71%
Kardigan
Nov 7, 2026
Reiterated: Buy
Price Target: $50
Current: $13.82
Upside: +261.79%
ADMA Biologics
Nov 5, 2026
Reiterated: Hold
Price Target: $12 → $13
Current: $13.68
Upside: -4.97%
Celldex Therapeutics
Nov 5, 2026
Reiterated: Buy
Price Target: $72
Current: $28.83
Upside: +149.74%
Egetis Therapeutics AB (publ)
Nov 5, 2026
Downgraded: Hold
Price Target: kr 33.00 → kr 11.25
Current: kr 11.20
Upside: +0.45%
Sarepta Therapeutics
Nov 5, 2026
Reiterated: Hold
Price Target: $21
Current: $16.07
Upside: +30.68%
Nov 3, 2026
Reiterated: Buy
Price Target: $39
Current: $16.08
Upside: +142.54%
Nov 3, 2026
Reiterated: Buy
Price Target: $87
Current: $29.72
Upside: +192.73%
Nov 3, 2026
Reiterated: Buy
Price Target: $25
Current: $9.08
Upside: +175.33%
Oct 29, 2026
Reiterated: Buy
Price Target: $137
Current: $63.49
Upside: +115.78%
Oct 28, 2026
Reiterated: Buy
Price Target: $48
Current: $11.02
Upside: +335.77%
Oct 28, 2026
Reiterated: Buy
Price Target: $441
Current: $273.09
Upside: +61.49%
Oct 28, 2026
Initiated Coverage: Buy
Price Target: $6
Current: $0.9999
Upside: +500.06%
Oct 23, 2026
Reiterated: Buy
Price Target: n/a
Current: $6.06
Upside: -
Oct 19, 2026
Rated: Buy
Price Target: $125 → $170
Current: $80.00
Upside: +112.50%
Oct 14, 2026
Reiterated: Buy
Price Target: $25
Current: $7.51
Upside: +232.89%
Sep 17, 2026
Reiterated: Buy
Price Target: $28 → $30
Current: $2.42
Upside: +1,139.67%
Sep 17, 2026
Reiterated: Buy
Price Target: $3
Current: $0.3075
Upside: +875.61%
Sep 15, 2026
Reiterated: Buy
Price Target: $26
Current: $6.84
Upside: +280.12%
Aug 11, 2026
Reiterated: Buy
Price Target: $11
Current: $1.16
Upside: +848.28%
Aug 11, 2026
Reiterated: Buy
Price Target: $19
Current: $4.10
Upside: +363.41%
Aug 6, 2026
Reiterated: Buy
Price Target: $16
Current: $6.35
Upside: +151.97%
Jun 25, 2026
Reiterated: Buy
Price Target: $11
Current: $3.91
Upside: +181.33%
Jun 17, 2026
Upgraded: Buy
Price Target: n/a
Current: $23.81
Upside: -
Mar 19, 2026
Reiterated: Buy
Price Target: $15 → $24
Current: $3.77
Upside: +536.60%
Mar 10, 2026
Reiterated: Hold
Price Target: $16
Current: $1.09
Upside: +1,367.89%
Nov 21, 2025
Reiterated: Buy
Price Target: $14
Current: $3.12
Upside: +348.72%
Jul 1, 2024
Reiterated: Buy
Price Target: $6 → $7
Current: $0.5584
Upside: n/a
May 13, 2024
Rated: Buy
Price Target: n/a
Current: $3.98
Upside: n/a
Feb 4, 2024
Reiterated: Buy
Price Target: $6
Current: $0.9146
Upside: n/a
Aug 30, 2023
Downgraded: Hold
Price Target: $4 → $20
Current: $0.413
Upside: n/a
Aug 28, 2023
Reiterated: Buy
Price Target: $23
Current: $13.38
Upside: n/a
Jun 28, 2023
Reiterated: Buy
Price Target: $27
Current: $1.64
Upside: n/a
Jun 26, 2023
Reiterated: Buy
Price Target: $17
Current: $21.60
Upside: n/a
Jun 9, 2023
Rated: Hold
Price Target: n/a
Current: $1.53
Upside: n/a
May 15, 2023
Reiterated: Buy
Price Target: $3.5 → $28
Current: $0.1141
Upside: n/a
Mar 16, 2023
Downgraded: Hold
Price Target: $28 → $20
Current: $0.0001
Upside: n/a
Mar 10, 2023
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Dec 21, 2022
Reiterated: Hold
Price Target: $4.25 → $10
Current: $0.7317
Upside: n/a
Dec 29, 2021
Initiated Coverage: Buy
Price Target: $180
Current: $1.68
Upside: n/a
Sep 28, 2021
Reiterated: Hold
Price Target: $4
Current: $0.8278
Upside: n/a
May 12, 2021
Reiterated: Buy
Price Target: $10
Current: $0.4214
Upside: n/a
Mar 2, 2021
Initiated Coverage: Buy
Price Target: $22
Current: $0.0002
Upside: n/a
Nov 30, 2020
Initiated Coverage: Buy
Price Target: $9
Current: $0.371
Upside: n/a